ABT-199

CAS No. 1257044-40-8

ABT-199 ( GDC-0199 )

Catalog No. M11056 CAS No. 1257044-40-8

Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 61 In Stock
25MG 75 In Stock
50MG 80 In Stock
100MG 104 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ABT-199
  • Note
    Research use only, not for human use.
  • Brief Description
    Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays.
  • Description
    Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays, >4800-fold more selective versus Bcl-xL and Bcl-w, and no activity to Mcl-1. Phase 3.
  • Synonyms
    GDC-0199
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Mcl-1; Bcl-2; Bcl-w; Bcl-xL
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1257044-40-8
  • Formula Weight
    868.44
  • Molecular Formula
    C45H50ClN7O7S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 100 mg/mL warmed (115.14 mM)
  • SMILES
    O=C(NS(=O)(C1=CC=C(NCC2CCOCC2)C([N+]([O-])=O)=C1)=O)C3=CC=C(N4CCN(CC5=C(C6=CC=C(Cl)C=C6)CC(C)(C)CC5)CC4)C=C3OC7=CN=C(NC=C8)C8=C7
  • Chemical Name
    4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Souers AJ, et al. Nat Med, 2013, 19(2), 202-208.
molnova catalog
related products
  • AZD 5991

    AZD 5991 (AZD5991) is a potent and selective macrocyclic inhibitor of Mcl-1 with sub-nanomolar affinity.

  • S55746

    S55746 (BCL201, Servier-1) is a novel potent, selective, orally bioavailable inhibitor of BCL-2 with Ki of 1.3 nM.

  • BCL6-IN-8

    BCL6-IN-8 (BCL6-i) is a potent, irreversible and cell-active BCL6 inhibitor with inact/KI value of 1.9 × 104 M-1 s-1, targets Cys53 located at the protein-protein interaction interface.